Picture of Aker Biomarine ASA logo

AKBM Aker Biomarine ASA News Story

0.000.00%
no flag iconLast trade - 00:00
Consumer DefensivesSpeculativeMid CapMomentum Trap

Brief: Aker Biomarine Expects Long-Term Average Annual Sales Growth At Around 15%

April 28 (Reuters) - Aker Biomarine ASA  AKBM.OL :
    * OUTLOOK FOR Q2 2023: WE EXPECT QRILL AQUA AND SUPERBA
REVENUES,
AS WELL AS BRANDS REVENUES TO BE ABOVE SAME QUARTER LAST YEAR
    * OUTLOOK : WE ALSO EXPECT SUPERBA SALES IN Q2 TO BE ON PAR
OR
ABOVE WITH Q1 2023
    * OUTLOOK : WE EXPECT LONG-TERM AVERAGE ANNUAL SALES GROWTH
FOR
AKER BIOMARINE TO BE IN LINE WITH EARLIER COMMUNICATED AMBITIONS
AT AROUND 15%

Source text for Eikon:  ID:nObijpHg6a 
Further company coverage:  AKBM.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Aker Biomarine ASA

See all news